MedTech Unleashed in Berlin
Join the exclusive MedTech event with Pilotfish, Zign Innovations, Corscience and Digital Health Works in Berlin on October 8, 2024.
“The Lean MedTech?
Fail Fast, Innovate Faster, Save Lives”
Under this motto, we invite you to the “MedTech Unleashed” event in Berlin on October 8, 2024 together with Pilotfish, Zign Innovations and Digital Health Works. Decision-makers and experts from the medical technology industry will gain exclusive insights into the development of innovative MedTech devices and have the opportunity to connect with industry peers.
Keynote
Prof. Dr. Ulrich-Wilhelm Thomale, Head of Pediatric Neurosurgery at Charité – Universitätsmedizin Berlin, will talk about the opportunities and challenges
for innovation in the MedTech sector. He will be sharing his personal experience of how medical and technical expertise must go hand in hand in order to improve healthcare practice.
Breakout-Sessions
- Pilotfish: “Starting Your Journey in Human-Centered Medical Device Development”
- Zign Innovations: “5 Key Factors for Successful Medical Device Development”
- Corscience: “The essential role of risk assessment in product development and the lifecycle of medical devices”
- Digital Health Works: “Going to the US – Internationalizing your Medical Technology”
Registration and information
Secure your spot at “MedTech Unleashed” now. Click on the button below to register and learn more about the event.
For further information please contact Dorothee Ogiermann-Kitz.
Event partners
Pilotfish: Specializing in human-centered design, Pilotfish supports companies in the development of user-centered devices.
Zign Innovations: Supports the development and production of electronic medical devices, from the idea to the market launch.
Corscience: Offers customized solutions for defibrillation, monitoring and intensive care technology as well as technical and regulatory consulting for safe, life-saving technologies.
Digital Health Works: Provides medtech start-ups with support for international expansion and regulatory issues.